- Generic Name:
- Drug Type:
- Kinase inhibitor
- How the Drug is Given:
Indications and Usage
Ayvakit™ is indicated for the treatment of adult patients with Advanced Systemic Mastocytosis (AdvSM). AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SMAHN), and mast cell leukemia (MCL).
Limitations of Use: AYVAKIT is not recommended for the treatment of patients with AdvSM with platelet counts of less than 50 X 109 /L.
Side effects needing medical attention
The most common adverse reactions for AdvSM are: edema, diarrhea, nausea, and fatigue/asthenia.